Zobrazeno 1 - 10
of 56
pro vyhledávání: '"alda scale"'
Autor:
Dong Eun Lee, Ji Hyun Baek
Publikováno v:
Precision and Future Medicine, Vol 8, Iss 2, Pp 33-37 (2024)
Lithium is the first-line medication for the treatment of bipolar disorder (BD), but its exact biological mechanisms have not been identified. One of the major obstacles in lithium-related research is the difficulty in precisely and reliably measurin
Externí odkaz:
https://doaj.org/article/be665d7582ff403598331801e4987ce5
Autor:
Anna Maria Iazzolino, Marta Valenza, Martina D’Angelo, Grazia Longobardi, Valeria Di Stefano, Steardo Luca, Caterina Scuderi, Luca Steardo jr
Publikováno v:
International Journal of Bipolar Disorders, Vol 12, Iss 1, Pp 1-9 (2024)
Abstract Background Multiple traumatic experiences, particularly in childhood, may predict and be a risk factor for the development of complex post-traumatic stress disorder (cPTSD). Unfortunately, individuals with bipolar disorder (BP) are more like
Externí odkaz:
https://doaj.org/article/5a94193269494559b92d9393141f232f
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
K. Altınbaş
Publikováno v:
European Psychiatry, Vol 65, Pp S406-S407 (2022)
Introduction Suicide risk is 20-30 fold higher in bipolar disorder(BD) than general population. A positive family history of suicide, early-onset bipolar disorder, rapid cycling, and drug/alcohol addiction have been identified as risk factors for non
Externí odkaz:
https://doaj.org/article/5a7984cf56ab49e1bf4cd615ee8c9d53
Autor:
Jinyoung Lee, Ji Hyun Baek, Dongbin Lee, Sung Woo Ahn, So-Yung Yang, Yujin Choi, Yong Chun Bahk, Kyung Sue Hong
Publikováno v:
International Journal of Bipolar Disorders, Vol 8, Iss 1, Pp 1-11 (2020)
Abstract Background When evaluating the long-term treatment response to mood stabilizers using the Alda scale, mood stabilizer combination therapy is typically considered a confounding factor, and patients receiving combination therapy are excluded f
Externí odkaz:
https://doaj.org/article/60aa24656d4e48999feb5aebadd10a10
Autor:
Sung Woo Ahn, Ji Hyun Baek, So-Yung Yang, Yongkang Kim, Youngah Cho, Yujin Choi, Kounseok Lee, Taesung Park, Kyung Sue Hong
Publikováno v:
International Journal of Bipolar Disorders, Vol 5, Iss 1, Pp 1-9 (2017)
Abstract Background The efficacy and utility of long-term prophylactic treatment in patients with bipolar disorders (BDs) have not been fully explored. This study aims to estimate the long-term clinical response of patients with BDs to mood stabilize
Externí odkaz:
https://doaj.org/article/a6819e22bafd4ea0a212404c5657ad6e
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
U. Heilbronner
Publikováno v:
Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева, Vol 0, Iss 4-1, Pp 51-52 (2019)
Lithium is an indispensable tool of modern psychiatry. Although it is well-known that response to lithium is a familial trait, available research on pharmacogenetics regarding lithium treatment has, in the past, produced few reproducible results. The
Externí odkaz:
https://doaj.org/article/56b5b27a808449fda58fd128da190096
Autor:
U. Heilbronner
Publikováno v:
Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева, Vol 0, Iss 4-1, Pp 26-27 (2019)
Lithium remains a first-line pharmacological treatment of bipolar disorder (BD). However, treatment response is heterogeneous, with several lines of evidence implicating genetic factors. Unfortunately, neither hypothesis-driven approaches nor initial
Externí odkaz:
https://doaj.org/article/bccfd54e9c6243a8931513c4fefee66c
Autor:
Kyung Sue Hong, So-Yung Yang, Sung Woo Ahn, Dongbin Lee, Ji Hyun Baek, Yong-Chun Bahk, Jin Young Lee, Yujin Choi
Publikováno v:
International Journal of Bipolar Disorders, Vol 8, Iss 1, Pp 1-11 (2020)
International Journal of Bipolar Disorders
International Journal of Bipolar Disorders
Background When evaluating the long-term treatment response to mood stabilizers using the Alda scale, mood stabilizer combination therapy is typically considered a confounding factor, and patients receiving combination therapy are excluded from the a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e36845c552eb6c56f5a44a7f2a69d110
http://link.springer.com/article/10.1186/s40345-020-00199-w
http://link.springer.com/article/10.1186/s40345-020-00199-w